Extra-articular inflammatory sites detected by F-18 FDG PET/CT in a patient with rheumatoid arthritis

Clinical Nuclear Medicine

Volumn 35, Issue 7, 2010, Pages 540-541

  Dos Anjos, Dalton Alexandre ^a,b   Do Vale, Georges Ferreira ^a   De Mello Campos, Cejana ^a   Monteiro Prado, Leonardo Fonseca ^a   Sobrinho, Alaor Barra ^a   Rodrigues Da Cunha, Alexandre Lima ^a   Moraes Santos, Anna Carolina ^a  

^a Department of Nuclear Medicine and Radiology   (Brazil)

^b SHLS 716   (Brazil)

Author keywords

F 18 FDG PET CT; false positive; imaging; inflammation; rheumatoid arthritis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; AXILLARY LYMPH NODE; CASE REPORT; CERVICAL LYMPH NODE; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; FALSE POSITIVE RESULT; FEMALE; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; NEOPLASM; PELVIS LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; RHEUMATOID ARTHRITIS; SUBCUTANEOUS NODULE; SYMPTOM;

ADULT; ARTHRITIS, RHEUMATOID; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATION; JOINTS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77954023301     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181e05eb9     Document Type: Article

References (11)

1. Haraoui B. Assessment and management of rheumatoid arthritis. J Rheumatol Suppl. 2009;82:2-10.
2. Nishimura K, Sugiyama D, Kogata Y, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007;146:797-808.
3. Smolen JS, Aletaha D. Developments in the clinical understanding of rheumatoid arthritis. Arthritis Res Ther. 2009;11:204.
4. Fletcher JW, Djulbegovic B, Soares HP, et al. Recommendations on the Use of F-18 FDG PET in Oncology. J Nucl Med. 2008;49:480-508.
5. Jhanwar YS, Straus DJ. The role of PET in lymphoma. J Nucl Med. 2007;48:1626-1632.
6. Cook GJ. Pitfalls in PET/CT interpretation. Q J Nucl Med Mol Imaging. 2007;51:235-243.
7. Metser U, Even-Sapir E. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/ computed tomography (PET/CT): accumulated data from four years of experience with PET/CT. Semin Nucl Med. 2007;37:206-222.
8. Rosenbaum SJ, Lind T, Antoch G, et al. False-positive FDG PET uptake-the role of PET/CT. Eur Radiol. 2006;16:1054-1065.
9. Kostakoglu L, Hardoff R, Mirtcheva R, et al. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics. 2004;24:1411-1431.
10. Beckers C, Ribbens C, André B, et al. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med. 2004;45:956-964.
11. Seldin DW, Habib I, Soudry G. Axillary lymph node visualization on F-18 FDG PET body scans in patients with rheumatoid arthritis. Clin Nucl Med. 2007;32:524-526.